title: Cryptococcal meningitis in an HIV-negative patient with rheumatoid arthritis treated with rituximab.
authors.forename: Tom
authors.initials: T
authors.lastname: Wingfield
authors.forename: Meghna
authors.initials: M
authors.lastname: Jani
authors.forename: Maria
authors.initials: M
authors.lastname: Krutikov
authors.forename: Josephine
authors.initials: J
authors.lastname: Mayer
authors.forename: Alison
authors.initials: A
authors.lastname: Uriel
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Marks
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Ustianowski
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003455:Cryptococcus neoformans / Q000302:isolation & purification; D006801:Humans; D000069285:Infliximab; D008297:Male; D016919:Meningitis, Cryptococcal / Q000139:chemically induced*; D000069283:Rituximab; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069283:Rituximab; D000069285:Infliximab